These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26717215)

  • 21. [Analysis of P wave duration and dispersion in paroxysmal atrial fibrillation].
    Lelakowska-Pieła M; Pudło J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):259-62. PubMed ID: 24575644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive prediction of catheter ablation outcome in persistent atrial fibrillation by fibrillatory wave amplitude computation in multiple electrocardiogram leads.
    Zarzoso V; Latcu DG; Hidalgo-Muñoz AR; Meo M; Meste O; Popescu I; Saoudi N
    Arch Cardiovasc Dis; 2016 Dec; 109(12):679-688. PubMed ID: 27402153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography.
    Wang YC; Lin LC; Lin MS; Lai LP; Hwang JJ; Tseng YZ; Tseng CD; Lin JL
    Cardiology; 2005; 104(4):202-9. PubMed ID: 16155395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detailed ECG analysis of atrial repolarization in humans.
    Holmqvist F; Carlson J; Platonov PG
    Ann Noninvasive Electrocardiol; 2009 Jan; 14(1):13-8. PubMed ID: 19149788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: results from a randomized prospective study.
    Nührich JM; Steven D; Berner I; Rostock T; Hoffmann B; Servatius H; Sultan A; Lüker J; Treszl A; Wegscheider K; Willems S
    Heart Rhythm; 2014 Sep; 11(9):1536-42. PubMed ID: 24907643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the morphology and duration between premature P waves and the preceding sinus complexes in patients with a history of paroxysmal atrial fibrillation.
    Dilaveris PE; Pantazis A; Zervopoulos G; Kallikazaros J; Stefanadis C; Toutouzas PK
    Clin Cardiol; 2003 Jul; 26(7):341-7. PubMed ID: 12862301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of an algorithm to reveal the U wave in atrial fibrillation.
    Al-Karadi MS; Wilkinson AJ; Caldwell J; Langley P
    Sci Rep; 2018 Aug; 8(1):11946. PubMed ID: 30093703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of new onset atrial fibrillation through P wave analysis in 12 lead ECG.
    Yoshizawa T; Niwano S; Niwano H; Igarashi T; Fujiishi T; Ishizue N; Oikawa J; Satoh A; Kurokawa S; Hatakeyama Y; Fukaya H; Ako J
    Int Heart J; 2014; 55(5):422-7. PubMed ID: 25098176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.
    Sauer AJ; Kaplan R; Xue J; Dorsey P; Hayes M; Shah SJ; Passman R
    Am J Cardiol; 2014 Jun; 113(12):2030-5. PubMed ID: 24793679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation.
    Kubara I; Ikeda H; Hiraki T; Yoshida T; Ohga M; Imaizumi T
    J Cardiovasc Electrophysiol; 1999 May; 10(5):670-9. PubMed ID: 10355923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of P-Wave Duration and Morphologic Variability to Identify Patients Prone to Paroxysmal Atrial Fibrillation.
    Conte G; Luca A; Yazdani S; Caputo ML; Regoli F; Moccetti T; Kappenberger L; Vesin JM; Auricchio A
    Am J Cardiol; 2017 Jan; 119(2):275-279. PubMed ID: 27823601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unmasking of atrial repolarization waves using a simple modified limb lead system.
    Jayaraman S; Gandhi U; Sangareddi V; Mangalanathan U; Shanmugam RM
    Anatol J Cardiol; 2015 Aug; 15(8):605-10. PubMed ID: 25550180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after cardioversion of atrial fibrillation: prediction of recurrence with P wave signal averaged ECG and chemoreflexsensitivity.
    Budeus M; Wieneke H; Sack S; Erbel R; Perings C
    Int J Cardiol; 2006 Oct; 112(3):308-15. PubMed ID: 16309759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-wave dispersion index: a marker of patients with paroxysmal atrial fibrillation.
    Villani GQ; Piepoli M; Rosi A; Capucci A
    Int J Cardiol; 1996 Jul; 55(2):169-75. PubMed ID: 8842787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial electrical abnormality in patients with Brugada syndrome assessed by signal-averaged electrocardiography.
    Nagamoto Y; Fujii Y; Morita Y; Ueda Y; Miyake Y; Yamane K; Fujiwara M; Mito S; Watari Y; Tamekiyo H; Okimoto T; Muraoka Y; Hayashi Y
    Indian Heart J; 2017; 69(6):714-719. PubMed ID: 29174247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of exercise to P wave dispersion and its evaluation as a predictor of atrial fibrillation.
    Yiğit Z; Akdur H; Ersanli M; Okçün B; Güven O
    Ann Noninvasive Electrocardiol; 2003 Oct; 8(4):308-12. PubMed ID: 14516287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [P-wave ekg averaging technique--a new method of selecting patients with paroxysmal atrial fibrillation].
    Opolski G; Kraska T; Piatkowska-Janko E; Słomka K; Górecki A; Stanisławska J; Scisło P; Piatkowski A; Cieciura M
    Pol Tyg Lek; 1995 Oct; 50(40-44):39-41. PubMed ID: 8650057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation: advanced echocardiographic evaluation of the left atrium combined with non-invasive P-wave analysis.
    Girasis C; Vassilikos V; Efthimiadis GK; Papadopoulou SL; Dakos G; Dalamaga EG; Chouvarda I; Giannakoulas G; Kamperidis V; Paraskevaidis S; Maglaveras N; Karvounis HI; Parcharidis GE; Styliadis IH
    Eur Heart J Cardiovasc Imaging; 2013 May; 14(5):425-34. PubMed ID: 22902322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave dispersion.
    Köse S; Aytemir K; Sade E; Can I; Ozer N; Amasyali B; Aksöyek S; Ovünç K; Ozmen F; Atalar E; Işik E; Kes S; Demirtaş E; Oto A
    Clin Cardiol; 2003 Sep; 26(9):431-4. PubMed ID: 14524601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of sotalol hydrochloride therapy on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
    Telichowski A; Banasiak W; Wiech K; Zeborowski J; Pieróg M; Ponikowski P; Kałka D; Lacheta W; Fuglewicz A; Telichowski C
    Pol Merkur Lekarski; 1996 Nov; 1(5):303-9. PubMed ID: 9273201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.